Low Incidence of Delayed Intracranial Hemorrhage Seen in Seniors After Head Injury
By Elana Gotkine HealthDay Reporter
WEDNESDAY, July 3, 2024 -- Older emergency department head trauma patients appear to have a very low incidence of delayed intracranial hemorrhage (ICH) after head injury, with no difference in rates based on prior anticoagulant use, according to a study published online June 13 in The Journal of Emergency Medicine.
Richard D. Shih, M.D., from Florida Atlantic University in Boca Raton, and colleagues examined the incidence of delayed ICH in geriatric emergency department head trauma patients prescribed anticoagulants preinjury in a prospective cohort study conducted at two hospital emergency departments. The incidence of delayed ICH, defined as an initial negative head computed tomography scan, followed by subsequent ICH believed to be caused by the initial event, was examined; the rate was compared between patient cohorts based on anticoagulant use.
Of the 3,425 patients enrolled, 67.2 percent were not on an anticoagulant, 7 percent were on preinjury warfarin, 22.7 percent were on a direct acting oral anticoagulant, and 2.8 percent were on enoxaparin or heparin. The researchers found that 6.7 percent of the participants had an acute ICH, and 0.4 percent had a delayed ICH. The rates of delayed ICH did not significantly differ between those who had versus had not been prescribed anticoagulants.
"Given the infrequency of delayed ICH, little current information exists regarding risk factors for the development of delayed ICH, an important question for future research," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-07-04 01:15
Read more
- Children Have Various Symptoms Within Five Years Before MS Diagnosis
- GSK’s B7-H3-Targeted Antibody-Drug Conjugate, GSK’227, Receives US FDA Breakthrough Therapy Designation in Late-Line Relapsed or Refractory Osteosarcoma
- Upadacitinib Improves Ulcerative Colitis Outcomes at 12 Months
- Poststroke Epilepsy Risk Varies With Antihypertensive Treatment
- Study Quantifies Global T2DM, CVD Burdens Attributable to Sugary Drinks
- People With Lupus Are At Risk for This Type of Heart Disease
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions